IDEAS home Printed from https://ideas.repec.org/a/eee/hepoli/v28y1994i1p1-13.html
   My bibliography  Save this article

The cost-effectiveness of the switch towards more expensive antihypertensive drugs

Author

Listed:
  • Johannesson, Magnus

Abstract

No abstract is available for this item.

Suggested Citation

  • Johannesson, Magnus, 1994. "The cost-effectiveness of the switch towards more expensive antihypertensive drugs," Health Policy, Elsevier, vol. 28(1), pages 1-13, March.
  • Handle: RePEc:eee:hepoli:v:28:y:1994:i:1:p:1-13
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/0168-8510(94)90016-7
    Download Restriction: Full text for ScienceDirect subscribers only
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Aslam Anis & Huiying Sun & Sonia Singh & John Woolcott & Bohdan Nosyk & Marc Brisson, 2006. "A Cost-Utility Analysis of Losartan versus Atenolol in the Treatment of Hypertension with Left Ventricular Hypertrophy," PharmacoEconomics, Springer, vol. 24(4), pages 387-400, April.
    2. Francis Pang & Mike Drummond & Fujian Song, 1999. "The use of meta-analysis in economic evaluation," Working Papers 173chedp, Centre for Health Economics, University of York.
    3. Joakim A. L. Ramsberg & Lennart Sjöberg, 1997. "The Cost‐Effectiveness of Lifesaving Interventions in Sweden," Risk Analysis, John Wiley & Sons, vol. 17(4), pages 467-478, August.
    4. Salkeld, Glenn & Phongsavan, Philayrath & Oldenburg, Brian & Johannesson, Magnus & Convery, Paula & Graham-Clarke, Peita & Walker, Sheila & Shaw, John, 1997. "The cost-effectiveness of a cardiovascular risk reduction program in general practice," Health Policy, Elsevier, vol. 41(2), pages 105-119, August.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:28:y:1994:i:1:p:1-13. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.